Skip to main content
Equibles

Centerpoint Advisors, LLC

Position in RNA — Atrium Therapeutics, Inc.

CIK 1733788 NEEDHAM, MA
Back to RNA Full portfolio

Position in RNA

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$67
+$1 QoQ
Shares Held
5
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#150
of 154 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in RNA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Centerpoint Advisors, LLC holds $114,760 across 8 Biotechnology names. RNA ranks #7 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 87 $43,215
2 HALO
Halozyme Therapeutics, Inc.
 545 $42,657
3 ARGX
Argenx SE
 30 $27,833
4 GERN
Geron Corp
 300 $384
5 NMRA
Neumora Therapeutics, Inc.
 220 $374
6 YARW
Yarrow Bioscience, Inc.
 7 $227
7 RNA
Atrium Therapeutics, Inc.
This page 		5 $67
8 PHVS
Pharvaris N.V.
 100 $3

All Filings in RNA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $67 5
2026-03-31 $66 5